FDA Letter API

Santos Agency Inc.

Letter data

Company
Santos Agency Inc.
Recipient
Santos Agency Inc. | United States
Issue date
2018-04-02
Posted date
Not available
FDA office
United States
Subject
Not available
Product
Not available
CMS ID
521298
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Santos Agency Inc. MARCS-CMS 521298 — April 02, 2018 More Warning Letters Warning Letters About Warning and Close-Out Letters Recipient: Santos Agency Inc. United States Issuing Office: United States Office of Human and Animal Foods Division West 5 San Francisco District Office 1431 Harbor Bay Parkway, Alameda, CA 94502 Telephone: 510-337-6700 UNITED PARCEL SERVICE SIGNATURE REQUIRED April 02, 2018 Mr. Santos Parmar, Manager Santo Agency Inc. 1188 Montague Street San Leandro, CA 94577 Dear Mr. Santos Parmar: The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter (CMS # 521298), dated April 03, 2017. Based on our evaluation, it appears that you have addressed the violation(s) contained in thisWarning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Sergio Chavez, Director of Compliancegiant Content current as of: 04/03/2018